	Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer. Cancer Sci Teramoto K, Kaku R, Igarashi T, Hashimoto M, Kitamura S, Motoishi M, Suzumura Y, Sawai S, Daigo Y, Hanaoka J. PMID: 42285905 [PubMed - as supplied by publisher]
	RRBP1 promotes osimertinib resistance by activating fatty acid oxidation-dependent metabolic and immune reprogramming in EGFR-Mutant lung adenocarcinoma. Biochem Pharmacol Huang Y, Zhang Y. PMID: 42285369 [PubMed - as supplied by publisher]
	Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation study. Cancer Lett Wang C, Dong X, Zhang G, Ren N, Chen X, Xie J, Shi X, Guo Z, Zheng Y, Luo Z, Zhu X, Cao W, Wang F, Tan F, Li N, He J. PMID: 42285215 [PubMed - as supplied by publisher]
	Molecular insights and therapeutic implications for the tumor suppressor role of LKB1 in Non-Small Cell Lung Cancer. Cancer Lett Yan P, Jiang W, Xue X, Hou T, Wang J, Huang D, Chen L, Inuzuka H, Dai X, Wei W. PMID: 42285213 [PubMed - as supplied by publisher]
	Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell lung cancer: An international study. Cancer Treat Res Commun Samol J, Demedts I, Erman M, Kozlov V, Minatta JN, Moiseenko F, Mark M, Rajappa S, Bailey T, Wallis H, Servidio L, Kahangire DA, Zukin M. PMID: 42284848 [PubMed - as supplied by publisher]
	Predicting recurrence within 5 years in Early-Stage lung adenocarcinoma with micropapillary and solid patterns. Int J Med Inform Wang Z, Chen J, Xu Y, Lin T, Chen C, Shen Y, Huang J, Xu S, Chen S. PMID: 42284830 [PubMed - as supplied by publisher]
	Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020). JCO Precis Oncol Leonetti A, Pluchino M, Minari R, Passiglia F, Pizzutilo EG, Cortinovis DL, Toschi L, Gelsomino F, Frega S, Metro G, Belluomini L, Montrone M, Camerini A, Bertolini A, Baldini E, Mazzoni F, Bria E, Bertolini F, Del Conte A, Bordi P, Perrone F, Verzè M, D'Agnelli S, Onorini P, Cosenza A, Facchinetti F, Boni L, Tognetto M, Tiseo M. PMID: 42284541 [PubMed - in process]
	Classifying family resilience trajectory of patients undergoing lung cancer surgery: a longitudinal study. Support Care Cancer Gao SR, Zhu J, Yan H, Xu H, Wu XY, Luo GH, Li XT, Ye M. PMID: 42283863 [PubMed - in process]
	How Wide is the Screening Window for Aggressive Non-Small Cell Lung Cancers? The Cure Threshold Metric and its Implications for Lung Cancer Screening Guidelines. Cancer Epidemiol Biomarkers Prev Goldwasser DL. PMID: 42283747 [PubMed - as supplied by publisher]
	Female underrepresentation and adverse events reporting biases in lung cancer clinical trials: a systematic review and meta-analysis. J Natl Cancer Cent Gan Y, Tian R, Han S, Zeng H, Sun F. PMID: 42282126 [PubMed]
	Liquid Biopsy Biomarkers for Predicting and Monitoring Immunotherapy Response in Lung Cancer. Cancers (Basel) Serio VB, Regoli T, Frullanti E, Palmieri M. PMID: 42279422 [PubMed]
	Pulmonary Embolism in Patients with Lung Cancer: Incidence and Performance of Prognostic Markers. Cancers (Basel) Tannura F, Sbrana A, Chella A, Pistelli F, Carrozzi L, Celi A, Pancani R. PMID: 42279420 [PubMed]
	Molecular Analysis of EBUS-TBNA Samples for Nodal Staging in Non-Small Cell Lung Cancer. Cancers (Basel) Ehab A, Benabdallah N, Darwiche K. PMID: 42279379 [PubMed]
	Peripheral CD8+ T Cell Dynamics and Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Following Bronchoscopic Cryotherapy and Pembrolizumab-Based Therapy. Cancers (Basel) Vasiliauskas G, , Skrodenien, Po, Miliauskas S, . PMID: 42279375 [PubMed]
	N1 Staging in Non-Small Cell Lung Cancer: Current Situation, Limitations, and the Importance of Peripheral Nodal Assessment. Cancers (Basel) Ishiwata T. PMID: 42279374 [PubMed]
	Review of Management of Clinical Stage I Small Cell Lung Cancer: The Rising Role of Surgical Resection. Cancers (Basel) Rasmussen GR, Klipsch E, Engelhardt KE. PMID: 42279364 [PubMed]
	Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study. Cancers (Basel) Bertolaccini L, Lombardi M, Chiari M, Rappa A, Casiraghi M, D'Ercole M, Mazzella A, Lo Iacono G, Mohamed S, Midolo De Luca V, Fusco N, Guerini Rocco E, Spaggiari L. PMID: 42279356 [PubMed]
	Lymph Node Sampling Patterns and Completeness of Staging During Systematic Mediastinal Lymph Node Staging in Patients with Locally Advanced Non-Small-Cell Lung Cancer: A Post Hoc Analysis from the SEISMIC Study. Cancers (Basel) Rangamuwa K, Witt A, Curran JM, Kothari G, Wallace N, Hardcastle N, Yo S, Bashirdazeh F, Nguyen P, Jennings BR, Fielding D, Crombag L, Yasufuku K, Annema JT, Ost D, Siva S, Steinfort DP. PMID: 42279349 [PubMed]
	Real-World Emulation of Landmark Lung Cancer Trials: A Registry-Based Reconstruction of KN189, KN407, IMpower133, and PACIFIC. Cancers (Basel) Surovtsova I, Eberhardt WEE, Meschke DE, Morakis P. PMID: 42279336 [PubMed]
	The Paradigm Shift in Clinical Stage II Non-Small-Cell Lung Cancer Management: A Comprehensive Review of Optimal Surgical and Systemic Approaches. Cancers (Basel) Wilson TW, Donington JS. PMID: 42279265 [PubMed]

Articles 1 - 20 / 160385

Page 1 of 8020



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy